Mapping Data Summary

• Symbol: Gsc2
• Name: goosecoid homebox 2
• ID: MGI:892006
• Chromosome: 16

9 mapping experiments

Experiment Type	Details	Chromosome	Reference
TEXT-Physical Mapping		16	J:44451 Botta A, et al., Comparative mapping of the DiGeorge syndrome region in mouse shows inconsistent gene order and differential degree of gene conservation. Mamm Genome. 1997 Dec;8(12):890-5
TEXT-Physical Mapping		16	J:58432 Kimber WL, et al., Deletion of 150 kb in the minimal DiGeorge/velocardiofacial syndrome critical region in mouse. Hum Mol Genet. 1999 Nov;8(12):2229-37
TEXT-Physical Mapping		16	J:60871 Lund J, et al., Comparative sequence analysis of 634 kb of the mouse chromosome 16 region of conserved synteny with the human velocardiofacial syndrome region on chromosome 22q11.2. Genomics. 2000 Feb 1;63(3):374-83
TEXT-Physical Mapping		16	J:54501 Lund J, et al., Sequence-ready physical map of the mouse chromosome 16 region with conserved synteny to the human velocardiofacial syndrome region on 22q11.2. Mamm Genome. 1999 May;10(5):438-43
TEXT-Physical Mapping		16	J:45079 Puech A, et al., Comparative mapping of the human 22q11 chromosomal region and the orthologous region in mice reveals complex changes in gene organization. Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14608-13
TEXT-Physical Mapping		16	J:64380 Puech A, et al., Normal cardiovascular development in mice deficient for 16 genes in 550 kb of the velocardiofacial/DiGeorge syndrome region. Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10090-5
TEXT-Physical Mapping		16	J:49844 Sutherland HF, et al., Cloning and comparative mapping of the DiGeorge syndrome critical region in the mouse. Genomics. 1998 Aug 15;52(1):37-43
TEXT-Physical Mapping		16	J:80000 The FANTOM Consortium and The RIKEN Genome Exploration Research Group Phase I & II Team, Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature. 2002;420:563-573
TEXT-QTL		16	J:38193 Galili N, et al., A region of mouse chromosome 16 is syntenic to the DiGeorge, velocardiofacial syndrome minimal critical region. (Correction: vol. 7(4):399). Genome Res. 1997 Jan;7(1):17-26